First quarter net revenues of $9.4 million reflecting 24.8% year-over-year growth
![Simulations Plus Sets Date for First Quarter Fiscal Year 2020 Earnings Release and Conference Call](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Sets Date for First Quarter Fiscal Year 2020 Earnings Release and Conference Call
Conference Call to be on Thursday, January 9, 2020, at 4:15 PM ET
![Simulations Plus Partners with Bayer AG to Develop New Cheminformatics Capabilities in ADMET Predictor](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Partners with Bayer AG to Develop New Cheminformatics Capabilities in ADMET Predictor
New Structure and Tautomer Handling Routines Aim to Improve Data Integrity in Drug Discovery
![Simulations Plus Partners with Large Pharmaceutical Company to Add New Capabilities to PKPlus](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Partners with Large Pharmaceutical Company to Add New Capabilities to PKPlus
Funded customization project will enhance and simplify high-throughput processing of PK/TK datasets
![Simulations Plus Partners with Large Pharmaceutical Company to Enhance the Mechanistic Oral Absorption (ACAT) Model in GastroPlus](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Partners with Large Pharmaceutical Company to Enhance the Mechanistic Oral Absorption (ACAT) Model in GastroPlus
Funded collaborative research effort adds new functionality to the top-rated simulation engine.
![Simulations Plus Reports FY2019 and Fourth Quarter FY2019 Financial Results](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Reports FY2019 and Fourth Quarter FY2019 Financial Results
Full-Year Revenue Increased 14.5% to $34 Million
![Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2019 Earnings Release and Conference Call](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2019 Earnings Release and Conference Call
Conference Call to be on Wednesday, November 13, 2019, at 4:15 PM ET
![Simulations Plus to Support Development of Radiation Countermeasure via New QSP Platform (RADAsym) and Pharmacometrics Modeling](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus to Support Development of Radiation Countermeasure via New QSP Platform (RADAsym) and Pharmacometrics Modeling
QSP and Pharmacometric Strategies Used to Aid Lifesaving Therapy for ARS
![Simulations Plus Partners with Large Pharmaceutical Company to Develop the Virtual Bioequivalence Trial Simulator™ Module](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Partners with Large Pharmaceutical Company to Develop the Virtual Bioequivalence Trial Simulator™ Module
Funded collaborative research effort strengthens the population simulation functionality in GastroPlus®
![Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
![Simulations Plus Announces Leadership Changes at Cognigen](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Announces Leadership Changes at Cognigen
Jill Fiedler-Kelly named President along with other promotions and key additions
![Simulations Plus Partners with Clinical-Stage Biotech Company to Develop Novel Dosing Models](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Partners with Clinical-Stage Biotech Company to Develop Novel Dosing Models
New intra-articular injection route will expand the suite of drug delivery options available in GastroPlus®
![Simulations Plus Enters into New Research Collaboration Agreement with the FDA](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Enters into New Research Collaboration Agreement with the FDA
Center for Veterinary Medicine to apply GastroPlus® to assess product bioequivalence in canines
![Simulations Plus Reports Third Quarter FY2019 Financial Results](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Reports Third Quarter FY2019 Financial Results
Record quarter as revenues grow 16%, 9MoFY19 revenues up 13%
Board of Directors announces quarterly dividend of $0.06 per share
![Simulations Plus Upgrades PKPlus™](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Upgrades PKPlus™
Enhancements include improved data handling and command line functionality
![Simulations Plus Sets Date for 3rd Quarter 2019 Earnings Release and Conference Call](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Sets Date for 3rd Quarter 2019 Earnings Release and Conference Call
Conference Call to be on Wednesday, July 10, 2019, at 4:15 PM ET
![DILIsym Releases NAFLDsym® Version 2A](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
DILIsym Releases NAFLDsym® Version 2A
Substantial update of NAFLD drug efficacy software offers a broad range of pathophysiology and over a thousand simulated patients for testing
![Simulations Plus Upgrades Flagship GastroPlus](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Simulations Plus Upgrades Flagship GastroPlus
User- and collaboration-driven functionality in version 9.7 expands the science of local and systemic exposure
![Cognigen Launches KIWI Version 4.0](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
Cognigen Launches KIWI Version 4.0
Exciting New Features to its Pharmacometric Communication and Collaboration Platform
![PMDA Adds Licenses of GastroPlus®](https://www.simulations-plus.com/wp-content/themes/simulations-plus/library/dist/img/default_square-large.jpg)
PMDA Adds Licenses of GastroPlus®
Japanese government organization to train reviewers to efficiently analyze PBPK model submissions